nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—STK24—female gonad—fallopian tube cancer	0.00204	0.00204	CbGeAlD
Sunitinib—STK24—vagina—fallopian tube cancer	0.00203	0.00203	CbGeAlD
Sunitinib—STK3—female reproductive system—fallopian tube cancer	0.00203	0.00203	CbGeAlD
Sunitinib—IRAK1—uterine cervix—fallopian tube cancer	0.00202	0.00202	CbGeAlD
Sunitinib—RPS6KA3—uterus—fallopian tube cancer	0.00202	0.00202	CbGeAlD
Sunitinib—DAPK2—female gonad—fallopian tube cancer	0.00202	0.00202	CbGeAlD
Sunitinib—DAPK2—vagina—fallopian tube cancer	0.00201	0.00201	CbGeAlD
Sunitinib—RPS6KB1—epithelium—fallopian tube cancer	0.002	0.002	CbGeAlD
Sunitinib—ROCK1—female reproductive system—fallopian tube cancer	0.002	0.002	CbGeAlD
Sunitinib—CSNK1E—endometrium—fallopian tube cancer	0.002	0.002	CbGeAlD
Sunitinib—RET—epithelium—fallopian tube cancer	0.00199	0.00199	CbGeAlD
Sunitinib—RPS6KB1—uterine cervix—fallopian tube cancer	0.00199	0.00199	CbGeAlD
Sunitinib—STK16—female gonad—fallopian tube cancer	0.00198	0.00198	CbGeAlD
Sunitinib—CSNK1A1—uterus—fallopian tube cancer	0.00198	0.00198	CbGeAlD
Sunitinib—TYRO3—female gonad—fallopian tube cancer	0.00197	0.00197	CbGeAlD
Sunitinib—HIPK3—female gonad—fallopian tube cancer	0.00197	0.00197	CbGeAlD
Sunitinib—HIPK2—female gonad—fallopian tube cancer	0.00197	0.00197	CbGeAlD
Sunitinib—STK16—vagina—fallopian tube cancer	0.00197	0.00197	CbGeAlD
Sunitinib—CLK1—uterus—fallopian tube cancer	0.00197	0.00197	CbGeAlD
Sunitinib—AXL—uterine cervix—fallopian tube cancer	0.00197	0.00197	CbGeAlD
Sunitinib—IRAK4—endometrium—fallopian tube cancer	0.00196	0.00196	CbGeAlD
Sunitinib—HIPK3—vagina—fallopian tube cancer	0.00196	0.00196	CbGeAlD
Sunitinib—TNK1—female gonad—fallopian tube cancer	0.00195	0.00195	CbGeAlD
Sunitinib—RIOK2—female gonad—fallopian tube cancer	0.00195	0.00195	CbGeAlD
Sunitinib—DYRK1A—female reproductive system—fallopian tube cancer	0.00195	0.00195	CbGeAlD
Sunitinib—TNK1—vagina—fallopian tube cancer	0.00194	0.00194	CbGeAlD
Sunitinib—RIOK2—vagina—fallopian tube cancer	0.00194	0.00194	CbGeAlD
Sunitinib—CAMK2G—uterus—fallopian tube cancer	0.00194	0.00194	CbGeAlD
Sunitinib—MAP4K1—vagina—fallopian tube cancer	0.00192	0.00192	CbGeAlD
Sunitinib—ULK3—endometrium—fallopian tube cancer	0.00192	0.00192	CbGeAlD
Sunitinib—MAP2K2—endometrium—fallopian tube cancer	0.00192	0.00192	CbGeAlD
Sunitinib—DAPK3—female gonad—fallopian tube cancer	0.0019	0.0019	CbGeAlD
Sunitinib—SLK—uterine cervix—fallopian tube cancer	0.00189	0.00189	CbGeAlD
Sunitinib—FGFR2—epithelium—fallopian tube cancer	0.00189	0.00189	CbGeAlD
Sunitinib—MAP3K7—endometrium—fallopian tube cancer	0.00189	0.00189	CbGeAlD
Sunitinib—DAPK3—vagina—fallopian tube cancer	0.00189	0.00189	CbGeAlD
Sunitinib—JAK2—epithelium—fallopian tube cancer	0.00188	0.00188	CbGeAlD
Sunitinib—CLK2—female gonad—fallopian tube cancer	0.00188	0.00188	CbGeAlD
Sunitinib—FGFR2—uterine cervix—fallopian tube cancer	0.00188	0.00188	CbGeAlD
Sunitinib—MAP4K4—female reproductive system—fallopian tube cancer	0.00187	0.00187	CbGeAlD
Sunitinib—MAP4K2—female gonad—fallopian tube cancer	0.00187	0.00187	CbGeAlD
Sunitinib—TBK1—endometrium—fallopian tube cancer	0.00187	0.00187	CbGeAlD
Sunitinib—CLK2—vagina—fallopian tube cancer	0.00187	0.00187	CbGeAlD
Sunitinib—JAK2—uterine cervix—fallopian tube cancer	0.00187	0.00187	CbGeAlD
Sunitinib—MAP4K2—vagina—fallopian tube cancer	0.00186	0.00186	CbGeAlD
Sunitinib—TYK2—endometrium—fallopian tube cancer	0.00186	0.00186	CbGeAlD
Sunitinib—STK3—female gonad—fallopian tube cancer	0.00185	0.00185	CbGeAlD
Sunitinib—MAP3K12—female reproductive system—fallopian tube cancer	0.00184	0.00184	CbGeAlD
Sunitinib—FLT3—female reproductive system—fallopian tube cancer	0.00184	0.00184	CbGeAlD
Sunitinib—FYN—uterine cervix—fallopian tube cancer	0.00184	0.00184	CbGeAlD
Sunitinib—CSNK1E—uterus—fallopian tube cancer	0.00184	0.00184	CbGeAlD
Sunitinib—FGFR1—uterus—fallopian tube cancer	0.00184	0.00184	CbGeAlD
Sunitinib—STK3—vagina—fallopian tube cancer	0.00183	0.00183	CbGeAlD
Sunitinib—ROCK1—female gonad—fallopian tube cancer	0.00182	0.00182	CbGeAlD
Sunitinib—RPS6KA3—female reproductive system—fallopian tube cancer	0.00182	0.00182	CbGeAlD
Sunitinib—MAP2K1—female reproductive system—fallopian tube cancer	0.00181	0.00181	CbGeAlD
Sunitinib—MAP4K5—uterine cervix—fallopian tube cancer	0.0018	0.0018	CbGeAlD
Sunitinib—MAP3K3—uterine cervix—fallopian tube cancer	0.0018	0.0018	CbGeAlD
Sunitinib—RPS6KB1—endometrium—fallopian tube cancer	0.0018	0.0018	CbGeAlD
Sunitinib—FGR—endometrium—fallopian tube cancer	0.00179	0.00179	CbGeAlD
Sunitinib—CSNK1A1—female reproductive system—fallopian tube cancer	0.00178	0.00178	CbGeAlD
Sunitinib—AXL—endometrium—fallopian tube cancer	0.00178	0.00178	CbGeAlD
Sunitinib—DYRK1A—female gonad—fallopian tube cancer	0.00178	0.00178	CbGeAlD
Sunitinib—CLK1—female reproductive system—fallopian tube cancer	0.00177	0.00177	CbGeAlD
Sunitinib—MAP2K2—uterus—fallopian tube cancer	0.00177	0.00177	CbGeAlD
Sunitinib—ULK3—uterus—fallopian tube cancer	0.00177	0.00177	CbGeAlD
Sunitinib—MAP3K2—uterus—fallopian tube cancer	0.00176	0.00176	CbGeAlD
Sunitinib—FLT1—epithelium—fallopian tube cancer	0.00175	0.00175	CbGeAlD
Sunitinib—MAP3K7—uterus—fallopian tube cancer	0.00174	0.00174	CbGeAlD
Sunitinib—CAMK2G—female reproductive system—fallopian tube cancer	0.00174	0.00174	CbGeAlD
Sunitinib—BMP2K—female reproductive system—fallopian tube cancer	0.00174	0.00174	CbGeAlD
Sunitinib—FLT1—uterine cervix—fallopian tube cancer	0.00174	0.00174	CbGeAlD
Sunitinib—MERTK—female gonad—fallopian tube cancer	0.00173	0.00173	CbGeAlD
Sunitinib—MERTK—vagina—fallopian tube cancer	0.00172	0.00172	CbGeAlD
Sunitinib—LRRK2—female reproductive system—fallopian tube cancer	0.00172	0.00172	CbGeAlD
Sunitinib—EPHB6—uterine cervix—fallopian tube cancer	0.00172	0.00172	CbGeAlD
Sunitinib—SLK—endometrium—fallopian tube cancer	0.00171	0.00171	CbGeAlD
Sunitinib—TYK2—uterus—fallopian tube cancer	0.00171	0.00171	CbGeAlD
Sunitinib—MAP4K4—female gonad—fallopian tube cancer	0.0017	0.0017	CbGeAlD
Sunitinib—PRKAA1—female reproductive system—fallopian tube cancer	0.0017	0.0017	CbGeAlD
Sunitinib—MAP4K4—vagina—fallopian tube cancer	0.00169	0.00169	CbGeAlD
Sunitinib—NUAK2—female gonad—fallopian tube cancer	0.00169	0.00169	CbGeAlD
Sunitinib—JAK2—endometrium—fallopian tube cancer	0.00169	0.00169	CbGeAlD
Sunitinib—NUAK2—vagina—fallopian tube cancer	0.00168	0.00168	CbGeAlD
Sunitinib—PTK2B—female reproductive system—fallopian tube cancer	0.00168	0.00168	CbGeAlD
Sunitinib—MAP3K12—female gonad—fallopian tube cancer	0.00168	0.00168	CbGeAlD
Sunitinib—FLT3—female gonad—fallopian tube cancer	0.00168	0.00168	CbGeAlD
Sunitinib—FLT4—female reproductive system—fallopian tube cancer	0.00168	0.00168	CbGeAlD
Sunitinib—MAP3K12—vagina—fallopian tube cancer	0.00167	0.00167	CbGeAlD
Sunitinib—FYN—endometrium—fallopian tube cancer	0.00166	0.00166	CbGeAlD
Sunitinib—YES1—uterine cervix—fallopian tube cancer	0.00166	0.00166	CbGeAlD
Sunitinib—RPS6KA3—female gonad—fallopian tube cancer	0.00166	0.00166	CbGeAlD
Sunitinib—CSNK1E—female reproductive system—fallopian tube cancer	0.00165	0.00165	CbGeAlD
Sunitinib—STK10—uterine cervix—fallopian tube cancer	0.00165	0.00165	CbGeAlD
Sunitinib—RPS6KA3—vagina—fallopian tube cancer	0.00165	0.00165	CbGeAlD
Sunitinib—MAP2K1—female gonad—fallopian tube cancer	0.00164	0.00164	CbGeAlD
Sunitinib—TAOK3—uterine cervix—fallopian tube cancer	0.00164	0.00164	CbGeAlD
Sunitinib—AXL—uterus—fallopian tube cancer	0.00164	0.00164	CbGeAlD
Sunitinib—MAP4K5—endometrium—fallopian tube cancer	0.00163	0.00163	CbGeAlD
Sunitinib—MAP3K3—endometrium—fallopian tube cancer	0.00163	0.00163	CbGeAlD
Sunitinib—CSNK1A1—female gonad—fallopian tube cancer	0.00162	0.00162	CbGeAlD
Sunitinib—CSNK1A1—vagina—fallopian tube cancer	0.00161	0.00161	CbGeAlD
Sunitinib—CLK1—female gonad—fallopian tube cancer	0.00161	0.00161	CbGeAlD
Sunitinib—CLK1—vagina—fallopian tube cancer	0.0016	0.0016	CbGeAlD
Sunitinib—ULK3—female reproductive system—fallopian tube cancer	0.00159	0.00159	CbGeAlD
Sunitinib—MAP2K2—female reproductive system—fallopian tube cancer	0.00159	0.00159	CbGeAlD
Sunitinib—BMP2K—female gonad—fallopian tube cancer	0.00158	0.00158	CbGeAlD
Sunitinib—CAMK2G—female gonad—fallopian tube cancer	0.00158	0.00158	CbGeAlD
Sunitinib—MAP3K2—female reproductive system—fallopian tube cancer	0.00158	0.00158	CbGeAlD
Sunitinib—SLK—uterus—fallopian tube cancer	0.00158	0.00158	CbGeAlD
Sunitinib—CAMK2G—vagina—fallopian tube cancer	0.00157	0.00157	CbGeAlD
Sunitinib—BMP2K—vagina—fallopian tube cancer	0.00157	0.00157	CbGeAlD
Sunitinib—FLT1—endometrium—fallopian tube cancer	0.00157	0.00157	CbGeAlD
Sunitinib—LRRK2—female gonad—fallopian tube cancer	0.00157	0.00157	CbGeAlD
Sunitinib—FGFR2—uterus—fallopian tube cancer	0.00156	0.00156	CbGeAlD
Sunitinib—LRRK2—vagina—fallopian tube cancer	0.00156	0.00156	CbGeAlD
Sunitinib—EPHB6—endometrium—fallopian tube cancer	0.00155	0.00155	CbGeAlD
Sunitinib—TBK1—female reproductive system—fallopian tube cancer	0.00155	0.00155	CbGeAlD
Sunitinib—PRKAA1—female gonad—fallopian tube cancer	0.00155	0.00155	CbGeAlD
Sunitinib—TYK2—female reproductive system—fallopian tube cancer	0.00154	0.00154	CbGeAlD
Sunitinib—FYN—uterus—fallopian tube cancer	0.00153	0.00153	CbGeAlD
Sunitinib—PTK2B—female gonad—fallopian tube cancer	0.00153	0.00153	CbGeAlD
Sunitinib—FLT4—female gonad—fallopian tube cancer	0.00152	0.00152	CbGeAlD
Sunitinib—PTK2B—vagina—fallopian tube cancer	0.00152	0.00152	CbGeAlD
Sunitinib—IRAK1—female reproductive system—fallopian tube cancer	0.00152	0.00152	CbGeAlD
Sunitinib—FGFR1—female gonad—fallopian tube cancer	0.0015	0.0015	CbGeAlD
Sunitinib—CSNK1E—female gonad—fallopian tube cancer	0.0015	0.0015	CbGeAlD
Sunitinib—YES1—endometrium—fallopian tube cancer	0.0015	0.0015	CbGeAlD
Sunitinib—MAP4K5—uterus—fallopian tube cancer	0.0015	0.0015	CbGeAlD
Sunitinib—CSNK1E—vagina—fallopian tube cancer	0.00149	0.00149	CbGeAlD
Sunitinib—FGFR1—vagina—fallopian tube cancer	0.00149	0.00149	CbGeAlD
Sunitinib—RPS6KB1—female reproductive system—fallopian tube cancer	0.00149	0.00149	CbGeAlD
Sunitinib—TAOK3—endometrium—fallopian tube cancer	0.00148	0.00148	CbGeAlD
Sunitinib—KDR—epithelium—fallopian tube cancer	0.00148	0.00148	CbGeAlD
Sunitinib—IRAK4—female gonad—fallopian tube cancer	0.00148	0.00148	CbGeAlD
Sunitinib—FGR—female reproductive system—fallopian tube cancer	0.00148	0.00148	CbGeAlD
Sunitinib—AXL—female reproductive system—fallopian tube cancer	0.00147	0.00147	CbGeAlD
Sunitinib—IRAK4—vagina—fallopian tube cancer	0.00147	0.00147	CbGeAlD
Sunitinib—KDR—uterine cervix—fallopian tube cancer	0.00147	0.00147	CbGeAlD
Sunitinib—MAP2K5—uterine cervix—fallopian tube cancer	0.00147	0.00147	CbGeAlD
Sunitinib—FLT1—uterus—fallopian tube cancer	0.00145	0.00145	CbGeAlD
Sunitinib—MAP2K2—female gonad—fallopian tube cancer	0.00145	0.00145	CbGeAlD
Sunitinib—ULK3—female gonad—fallopian tube cancer	0.00145	0.00145	CbGeAlD
Sunitinib—ULK3—vagina—fallopian tube cancer	0.00144	0.00144	CbGeAlD
Sunitinib—MAP3K2—female gonad—fallopian tube cancer	0.00144	0.00144	CbGeAlD
Sunitinib—CSF1R—uterine cervix—fallopian tube cancer	0.00143	0.00143	CbGeAlD
Sunitinib—MAP3K7—female gonad—fallopian tube cancer	0.00142	0.00142	CbGeAlD
Sunitinib—MAP3K7—vagina—fallopian tube cancer	0.00142	0.00142	CbGeAlD
Sunitinib—TBK1—female gonad—fallopian tube cancer	0.00141	0.00141	CbGeAlD
Sunitinib—FGFR2—female reproductive system—fallopian tube cancer	0.00141	0.00141	CbGeAlD
Sunitinib—TBK1—vagina—fallopian tube cancer	0.0014	0.0014	CbGeAlD
Sunitinib—TYK2—female gonad—fallopian tube cancer	0.0014	0.0014	CbGeAlD
Sunitinib—JAK2—female reproductive system—fallopian tube cancer	0.0014	0.0014	CbGeAlD
Sunitinib—TYK2—vagina—fallopian tube cancer	0.00139	0.00139	CbGeAlD
Sunitinib—YES1—uterus—fallopian tube cancer	0.00138	0.00138	CbGeAlD
Sunitinib—IRAK1—female gonad—fallopian tube cancer	0.00138	0.00138	CbGeAlD
Sunitinib—FYN—female reproductive system—fallopian tube cancer	0.00138	0.00138	CbGeAlD
Sunitinib—STK10—uterus—fallopian tube cancer	0.00137	0.00137	CbGeAlD
Sunitinib—TAOK3—uterus—fallopian tube cancer	0.00137	0.00137	CbGeAlD
Sunitinib—PDGFRA—uterus—fallopian tube cancer	0.00136	0.00136	CbGeAlD
Sunitinib—RPS6KB1—female gonad—fallopian tube cancer	0.00135	0.00135	CbGeAlD
Sunitinib—MAP3K3—female reproductive system—fallopian tube cancer	0.00135	0.00135	CbGeAlD
Sunitinib—MAP4K5—female reproductive system—fallopian tube cancer	0.00135	0.00135	CbGeAlD
Sunitinib—RPS6KB1—vagina—fallopian tube cancer	0.00135	0.00135	CbGeAlD
Sunitinib—FGR—female gonad—fallopian tube cancer	0.00135	0.00135	CbGeAlD
Sunitinib—AXL—female gonad—fallopian tube cancer	0.00134	0.00134	CbGeAlD
Sunitinib—FGR—vagina—fallopian tube cancer	0.00134	0.00134	CbGeAlD
Sunitinib—AXL—vagina—fallopian tube cancer	0.00133	0.00133	CbGeAlD
Sunitinib—KDR—endometrium—fallopian tube cancer	0.00133	0.00133	CbGeAlD
Sunitinib—MAP2K5—endometrium—fallopian tube cancer	0.00133	0.00133	CbGeAlD
Sunitinib—KIT—epithelium—fallopian tube cancer	0.00131	0.00131	CbGeAlD
Sunitinib—FLT1—female reproductive system—fallopian tube cancer	0.0013	0.0013	CbGeAlD
Sunitinib—KIT—uterine cervix—fallopian tube cancer	0.0013	0.0013	CbGeAlD
Sunitinib—CSF1R—endometrium—fallopian tube cancer	0.0013	0.0013	CbGeAlD
Sunitinib—SLK—female gonad—fallopian tube cancer	0.00129	0.00129	CbGeAlD
Sunitinib—PDGFRB—epithelium—fallopian tube cancer	0.00128	0.00128	CbGeAlD
Sunitinib—SLK—vagina—fallopian tube cancer	0.00128	0.00128	CbGeAlD
Sunitinib—FGFR2—female gonad—fallopian tube cancer	0.00128	0.00128	CbGeAlD
Sunitinib—PDGFRB—uterine cervix—fallopian tube cancer	0.00127	0.00127	CbGeAlD
Sunitinib—JAK2—female gonad—fallopian tube cancer	0.00127	0.00127	CbGeAlD
Sunitinib—JAK2—vagina—fallopian tube cancer	0.00126	0.00126	CbGeAlD
Sunitinib—FYN—female gonad—fallopian tube cancer	0.00125	0.00125	CbGeAlD
Sunitinib—FYN—vagina—fallopian tube cancer	0.00125	0.00125	CbGeAlD
Sunitinib—YES1—female reproductive system—fallopian tube cancer	0.00124	0.00124	CbGeAlD
Sunitinib—STK10—female reproductive system—fallopian tube cancer	0.00123	0.00123	CbGeAlD
Sunitinib—TAOK3—female reproductive system—fallopian tube cancer	0.00123	0.00123	CbGeAlD
Sunitinib—MAP3K3—female gonad—fallopian tube cancer	0.00123	0.00123	CbGeAlD
Sunitinib—MAP4K5—female gonad—fallopian tube cancer	0.00123	0.00123	CbGeAlD
Sunitinib—KDR—uterus—fallopian tube cancer	0.00123	0.00123	CbGeAlD
Sunitinib—PDGFRA—female reproductive system—fallopian tube cancer	0.00122	0.00122	CbGeAlD
Sunitinib—MAP3K3—vagina—fallopian tube cancer	0.00122	0.00122	CbGeAlD
Sunitinib—MAP4K5—vagina—fallopian tube cancer	0.00122	0.00122	CbGeAlD
Sunitinib—CSF1R—uterus—fallopian tube cancer	0.0012	0.0012	CbGeAlD
Sunitinib—FLT1—female gonad—fallopian tube cancer	0.00119	0.00119	CbGeAlD
Sunitinib—FLT1—vagina—fallopian tube cancer	0.00118	0.00118	CbGeAlD
Sunitinib—KIT—endometrium—fallopian tube cancer	0.00118	0.00118	CbGeAlD
Sunitinib—EPHB6—female gonad—fallopian tube cancer	0.00117	0.00117	CbGeAlD
Sunitinib—EPHB6—vagina—fallopian tube cancer	0.00116	0.00116	CbGeAlD
Sunitinib—PDGFRB—endometrium—fallopian tube cancer	0.00115	0.00115	CbGeAlD
Sunitinib—YES1—female gonad—fallopian tube cancer	0.00113	0.00113	CbGeAlD
Sunitinib—YES1—vagina—fallopian tube cancer	0.00113	0.00113	CbGeAlD
Sunitinib—STK10—female gonad—fallopian tube cancer	0.00112	0.00112	CbGeAlD
Sunitinib—TAOK3—female gonad—fallopian tube cancer	0.00112	0.00112	CbGeAlD
Sunitinib—STK10—vagina—fallopian tube cancer	0.00112	0.00112	CbGeAlD
Sunitinib—TAOK3—vagina—fallopian tube cancer	0.00111	0.00111	CbGeAlD
Sunitinib—PDGFRA—female gonad—fallopian tube cancer	0.00111	0.00111	CbGeAlD
Sunitinib—PDGFRA—vagina—fallopian tube cancer	0.0011	0.0011	CbGeAlD
Sunitinib—MAP2K5—female reproductive system—fallopian tube cancer	0.0011	0.0011	CbGeAlD
Sunitinib—KDR—female reproductive system—fallopian tube cancer	0.0011	0.0011	CbGeAlD
Sunitinib—KIT—uterus—fallopian tube cancer	0.00109	0.00109	CbGeAlD
Sunitinib—CSF1R—female reproductive system—fallopian tube cancer	0.00107	0.00107	CbGeAlD
Sunitinib—PDGFRB—uterus—fallopian tube cancer	0.00106	0.00106	CbGeAlD
Sunitinib—KDR—female gonad—fallopian tube cancer	0.001	0.001	CbGeAlD
Sunitinib—MAP2K5—female gonad—fallopian tube cancer	0.001	0.001	CbGeAlD
Sunitinib—KDR—vagina—fallopian tube cancer	0.000996	0.000996	CbGeAlD
Sunitinib—MAP2K5—vagina—fallopian tube cancer	0.000996	0.000996	CbGeAlD
Sunitinib—CSF1R—female gonad—fallopian tube cancer	0.000978	0.000978	CbGeAlD
Sunitinib—KIT—female reproductive system—fallopian tube cancer	0.000976	0.000976	CbGeAlD
Sunitinib—CSF1R—vagina—fallopian tube cancer	0.000972	0.000972	CbGeAlD
Sunitinib—PDGFRB—female reproductive system—fallopian tube cancer	0.000953	0.000953	CbGeAlD
Sunitinib—KIT—female gonad—fallopian tube cancer	0.000888	0.000888	CbGeAlD
Sunitinib—KIT—vagina—fallopian tube cancer	0.000883	0.000883	CbGeAlD
Sunitinib—PDGFRB—female gonad—fallopian tube cancer	0.000867	0.000867	CbGeAlD
Sunitinib—PDGFRB—vagina—fallopian tube cancer	0.000862	0.000862	CbGeAlD
Sunitinib—ABCC4—uterus—fallopian tube cancer	0.000844	0.000844	CbGeAlD
Sunitinib—KCNH2—uterine cervix—fallopian tube cancer	0.000804	0.000804	CbGeAlD
Sunitinib—ABCC4—female reproductive system—fallopian tube cancer	0.000759	0.000759	CbGeAlD
Sunitinib—ABCC2—female reproductive system—fallopian tube cancer	0.000735	0.000735	CbGeAlD
Sunitinib—KCNH2—endometrium—fallopian tube cancer	0.000727	0.000727	CbGeAlD
Sunitinib—ABCG2—uterine cervix—fallopian tube cancer	0.000715	0.000715	CbGeAlD
Sunitinib—ABCC4—female gonad—fallopian tube cancer	0.000691	0.000691	CbGeAlD
Sunitinib—KCNH2—uterus—fallopian tube cancer	0.00067	0.00067	CbGeAlD
Sunitinib—CYP3A5—uterine cervix—fallopian tube cancer	0.000664	0.000664	CbGeAlD
Sunitinib—ABCG2—endometrium—fallopian tube cancer	0.000647	0.000647	CbGeAlD
Sunitinib—KCNH2—female reproductive system—fallopian tube cancer	0.000602	0.000602	CbGeAlD
Sunitinib—ABCG2—uterus—fallopian tube cancer	0.000596	0.000596	CbGeAlD
Sunitinib—KCNH2—female gonad—fallopian tube cancer	0.000548	0.000548	CbGeAlD
Sunitinib—KCNH2—vagina—fallopian tube cancer	0.000545	0.000545	CbGeAlD
Sunitinib—ABCG2—female gonad—fallopian tube cancer	0.000487	0.000487	CbGeAlD
Sunitinib—ABCG2—vagina—fallopian tube cancer	0.000485	0.000485	CbGeAlD
Sunitinib—CYP3A5—female gonad—fallopian tube cancer	0.000453	0.000453	CbGeAlD
Sunitinib—CYP3A5—vagina—fallopian tube cancer	0.00045	0.00045	CbGeAlD
Sunitinib—CYP3A4—female reproductive system—fallopian tube cancer	0.000373	0.000373	CbGeAlD
Sunitinib—ABCB1—epithelium—fallopian tube cancer	0.000356	0.000356	CbGeAlD
Sunitinib—ABCB1—uterine cervix—fallopian tube cancer	0.000353	0.000353	CbGeAlD
Sunitinib—ABCB1—endometrium—fallopian tube cancer	0.000319	0.000319	CbGeAlD
Sunitinib—ABCB1—uterus—fallopian tube cancer	0.000294	0.000294	CbGeAlD
Sunitinib—ABCB1—female reproductive system—fallopian tube cancer	0.000264	0.000264	CbGeAlD
Sunitinib—ABCB1—female gonad—fallopian tube cancer	0.00024	0.00024	CbGeAlD
Sunitinib—ABCB1—vagina—fallopian tube cancer	0.000239	0.000239	CbGeAlD
